Ruijin Hospital Shanghai for International Patients
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine is a major public tertiary teaching hospital in central Shanghai. For international patients, it is especially relevant when the case involves hematologic cancer, CAR-T evaluation, diabetes or complex endocrine/metabolic disease, oncology, burns, or a multi-specialty medical problem that benefits from a large comprehensive hospital.
Quick answer: Ruijin combines a dedicated international medical service with major hematology and
endocrine/metabolic programs. Shanghai’s government publishes English service, a dedicated international contact,
direct-pay insurer information and a broad specialty list. In 2026, Shanghai Government also documented an overseas
multiple-myeloma patient whose case was discussed online before Ruijin’s international and hematology teams accepted
him for in-person evaluation and CAR-T treatment.
✓ Shanghai Government-listed international service
✓ Hematology + CAR-T pathway
✓ Endocrinology + metabolic disease
✓ Direct-pay insurer network published
Why International Patients Consider Ruijin Hospital
Ruijin is not a single-specialty hospital. It is a large comprehensive referral center, which makes it useful when the diagnosis crosses specialties or when the patient needs advanced diagnostics, hematology, metabolic medicine, oncology, critical care or surgery within the same institution.
Ruijin has deep hematology history and current translational programs in leukemia, lymphoma, multiple myeloma and cellular therapy.
Ruijin hosts national-level endocrine and metabolic research infrastructure and remains an important diabetes and metabolic-disease center.
International-service specialties published by Shanghai include cardiology, neurology, nephrology, gastroenterology, oncology, surgery and critical care.
Shanghai Government publishes a specific international-service location, phone, email, service hours and direct-pay insurer list.
Evidence checked against Shanghai Government, Shanghai Jiao Tong University School of Medicine and current 2026 sources in September 2026.
Ruijin Hospital Status and Institutional Role
Shanghai Jiao Tong University School of Medicine describes Ruijin as a Grade 3, Class A tertiary hospital and one of China’s National Medical Centers. Its institutional profile lists dozens of clinical specialties and national key clinical disciplines.
What this means for patients: national-center status and academic scale are useful indicators of
referral capability, but they are not the same as an independent ranking and do not prove that Ruijin is the best
hospital for every diagnosis.
Ruijin International Medical Service for Foreign Patients
Foreign-patient access is clearly documented. Shanghai’s official international medical-service
profile lists Ruijin at No. 197 Ruijin Road Number Two, Huangpu District, with outpatient service in
Building 10, English-language service, a dedicated contact number and email, and a published direct-pay insurer list.
Main international-service address
No. 197 Ruijin Road Number Two, Huangpu District, Shanghai
Published service hours
Monday–Saturday, 8:00–17:00
International contact
021-6467-8970
Email
vip@rjh.com.cn
Shanghai’s English profile confirms English service. Newer 2025 municipal-health profiles in other languages also list French, Japanese, Korean and Nepali support. Because language staffing can change by appointment, confirm the actual interpreter/language arrangement for the assigned specialist.
Which Ruijin Campus Should an International Patient Use?
Shanghai’s 2026 medical-institution directory lists multiple Ruijin campuses, including East, West, South and North locations. However, the city’s dedicated international-service profile points international patients to the main Huangpu campus at No. 197 Ruijin Road Number Two.
Do not assume every Ruijin campus has the same foreign-patient pathway. Unless the International
Medical Department tells you otherwise, use the main-campus international route for appointment planning and confirm
the exact building before travel.
Which Conditions Are a Strong Fit for Ruijin?
Leukemia & Blood Cancer
- Acute leukemia
- Acute promyelocytic leukemia
- Lymphoma
- Multiple myeloma
- Complex hematologic diagnosis
CAR-T Evaluation
- Selected hematologic malignancies
- Prior-treatment review
- T-cell and disease assessment
- Eligibility confirmation
- Post-treatment planning
Diabetes & Metabolic Disease
- Type 1 and Type 2 diabetes
- Difficult metabolic control
- Obesity / metabolic syndrome
- Endocrine tumors
- Complex endocrine diagnosis
Cancer Center
- Multidisciplinary cancer review
- General and thoracic surgery
- Radiotherapy questions
- Nuclear medicine
- Complex cancer comorbidity
Burn & Critical Care
- Major burns
- Complex wound care
- Critical care
- Reconstructive planning
- Multidisciplinary recovery
Complex Internal Medicine
- Cardiology
- Neurology
- Nephrology
- Gastroenterology
- Infectious disease
Ruijin Hospital for Leukemia, Lymphoma and Multiple Myeloma
Hematology is one of Ruijin’s most distinctive strengths. Shanghai Jiao Tong University School of Medicine lists hematology among Ruijin’s major national-level disciplines, and current faculty profiles show active clinical and translational work in leukemia, lymphoma, multiple myeloma and cellular immunotherapy.
Acute promyelocytic leukemia
Shanghai municipal-health profiles explicitly associate Ruijin with the historical “Shanghai solution” for acute promyelocytic leukemia (APL). That history is disease-specific and should not be generalized to every form of AML or leukemia.
Lymphoma and myeloma
Current Ruijin/SJTU faculty research includes lymphoma and multiple myeloma, including targeted and cellular therapies. International eligibility still depends on subtype, prior therapies, disease status and current protocol availability.
Translational hematology
Ruijin combines clinical hematology with laboratory and clinical-trial infrastructure. For a difficult case, send pathology, flow cytometry, cytogenetics/molecular testing and complete prior-treatment history.
CAR-T Therapy at Ruijin Hospital
Ruijin has current evidence of treating selected international hematology patients with CAR-T. A Shanghai Government patient story published in February 2026 describes an overseas patient with advanced multiple myeloma whose case was discussed online with Ruijin’s International Medical Department and hematology team before he traveled to Shanghai for a pre-treatment evaluation and CAR-T therapy.
Why this matters: this is unusually useful evidence because it confirms a real foreign-patient
pathway linking Ruijin’s international service and hematology team. It does not prove that CAR-T is
appropriate, available or approved for every patient or every cancer type.
Records for CAR-T screening
- Exact hematologic diagnosis and subtype
- Pathology / flow cytometry / bone marrow reports
- Cytogenetic and molecular findings
- Complete previous-treatment history and response
- Current blood counts, organ function and infection status
- Recent imaging where relevant
Questions Ruijin must answer
- Is there an appropriate licensed or study pathway for this diagnosis?
- Is the patient clinically eligible now?
- What bridging treatment may be needed?
- How long must the patient remain in Shanghai?
- What are the expected inpatient and follow-up requirements?
- What estimate applies to this exact pathway?
Related: CAR-T Therapy in China.
Ruijin Hospital for Diabetes and Endocrine Disease
Endocrine and metabolic medicine is another major Ruijin strength. Current academic sources identify the Shanghai National Clinical Research Center for Metabolic Diseases, endocrine/metabolic key laboratories and the Shanghai Institute of Endocrine and Metabolic Diseases within Ruijin’s academic network.
Diabetes
Ruijin is reasonable to consider for difficult Type 1 or Type 2 diabetes, metabolic complications, uncertain endocrine diagnosis and complex treatment optimization.
Metabolic disease and obesity
Ruijin researchers remain active in obesity, insulin resistance and metabolic disease. Clinical treatment must still be individualized rather than inferred from research activity.
Other endocrine disease
Current Ruijin academic work includes endocrine tumors, bone metabolism and other endocrine disorders. Send the actual hormone tests, imaging and previous endocrine work-up when seeking a specialist review.
Do not confuse endocrine strength with a guaranteed “diabetes cure.” Stem-cell, islet, pancreas or
other investigational treatment questions require separate verification of current studies, eligibility and
regulatory status. Routine diabetes management and experimental therapy are different intents.
Related: Diabetes Treatment in China · Best Diabetes Hospitals in China · Diabetes Clinical Trials in China.
Cancer Care at Ruijin: When a General Hospital Is Useful
Shanghai’s international-service profile lists a Cancer Center as well as general surgery, thoracic surgery, nuclear medicine, radiology and critical care. That broad structure can be useful when cancer treatment overlaps with major medical comorbidities or when hematology is central to the case.
Ruijin is not the only Shanghai cancer route. For a disease-specific solid-tumor case, a dedicated
cancer center such as Fudan University Shanghai Cancer Center may be a better comparison. Hospital choice should
follow tumor type, pathology, stage, treatment question and required technology.
Related: Cancer Treatment in China · Best Cancer Hospitals in China.
Burn Medicine and Critical Care
Burn medicine is one of Ruijin’s historically distinctive areas. Shanghai municipal-health profiles describe Ruijin as the origin of a burn shock-resuscitation approach known as the “Ruijin infusion formula,” while the current international-service specialty list still includes Burn Medicine and Critical Care Medicine.
Severe burns are emergencies. Do not delay stabilization or local emergency treatment while trying
to arrange international travel. Cross-border transfer should only be considered after the patient is stable and a
receiving team has agreed to the transfer.
Can Ruijin Review Records Before an International Patient Travels?
Public sources do not show a universal “buy a remote second opinion” product for every Ruijin specialty. However, Shanghai Government documented a 2025–2026 international hematology case in which the patient communicated online with Ruijin before the International Medical Department and hematology team accepted him for an in-person pre-treatment evaluation.
Practical interpretation: ask the International Medical Department whether the relevant team can
pre-review records before travel. For complex hematology, oncology, endocrine or surgical cases, this is more useful
than booking a generic outpatient slot without first identifying the correct department.
How International Patients Arrange an Appointment at Ruijin
Define the medical question
Leukemia, CAR-T, diabetes, endocrine disease and solid-tumor cases require different Ruijin teams.
Prepare the file
Send a concise summary plus imaging, pathology, molecular results and prior-treatment records where relevant.
Contact international service
Use the municipal-health contact 021-6467-8970 or vip@rjh.com.cn and ask for the appropriate department.
Confirm before travel
Confirm specialist/team, likely tests, language support, payment/insurance, admission and estimated stay.
Ruijin International Medical Service Contact Details
Address
No. 197 Ruijin Road Number Two, Huangpu District, Shanghai
Phone
021-6467-8970
Email
vip@rjh.com.cn
Published phone hours
Mon–Sat 08:00–11:30 and 13:30–16:30
The Shanghai Government profile lists international outpatient service in Building 10. Reconfirm the exact floor, department and registration instructions when the appointment is accepted.
Emergency Care at Ruijin vs the International Medical Department
A newer Shanghai municipal-health profile identifies Ruijin’s emergency service at Building 5, first floor. This should not be confused with the planned International Medical Department outpatient pathway in Building 10.
For an acute medical emergency, use the emergency pathway rather than waiting for an international
appointment. In mainland China, the medical emergency number is 120.
International Insurance and Direct Billing at Ruijin
Shanghai’s municipal-health profile publishes a substantial list of insurers providing direct-pay services through Ruijin’s international route. The list includes international assistance and insurance brands as well as Chinese commercial insurers.
Before relying on direct billing: send the exact insurer and policy information to Ruijin. Ask
whether the planned department and treatment are covered, whether preauthorization is required, whether the insurer
must issue a guarantee-of-payment letter, and what amount remains payable by the patient.
Published insurer lists can become stale. Inclusion on a municipal page is useful evidence of a
direct-pay relationship, but it is not a guarantee that every current policy or treatment is covered.
How Much Does Treatment at Ruijin Hospital Cost?
There is no credible universal Ruijin package price for an international patient. A diabetes
consultation, leukemia work-up, CAR-T pathway, cancer surgery, ICU admission and burn treatment are fundamentally
different episodes of care.
Diagnosis and work-up
Imaging, pathology, bone marrow studies, flow cytometry, molecular tests or endocrine investigations can materially affect the estimate.
Treatment technology
Cell therapy, high-cost drugs, surgery, radiation, devices and ICU support can dominate the total cost.
Length of stay
Ask separately for outpatient evaluation, inpatient deposit, expected admission length and post-discharge monitoring.
What Records Should You Send for a Ruijin Case Review?
For every complex case
- One-page medical summary
- Exact diagnosis or unresolved diagnostic question
- Symptoms and timeline
- Current medicines
- Previous admissions and procedures
- Recent laboratory results
- The exact decision you want Ruijin to answer
Specialty-specific evidence
- Hematology: marrow, flow cytometry, cytogenetics, molecular testing
- Cancer: pathology, molecular markers, CT/MRI/PET and DICOM
- Diabetes/endocrine: glucose/HbA1c, C-peptide, antibodies and endocrine tests as relevant
- Cardiac: ECG, echocardiography, angiography and procedure reports
- Prior treatment: drug names, doses, dates, response and complications
- Insurance details if direct billing matters
Ruijin vs Zhongshan vs Renji vs PUMCH
| Medical question | Ruijin | Other hospital to compare |
|---|---|---|
| Leukemia / lymphoma / myeloma / CAR-T | Strong hematology and cellular-therapy fit | Compare another disease-specific hematology center if a particular product, trial or transplant pathway is required. |
| Diabetes / complex endocrine disease | Strong endocrine/metabolic academic and clinical fit | Shanghai Sixth can be a Shanghai comparator for endocrinology/metabolism; compare by exact problem. |
| Cardiovascular / liver-focused case | Broad cardiology and tertiary support | Zhongshan may be the more obvious Shanghai comparator; Fuwai for highly specialized cardiovascular questions. |
| Gastroenterology / rheumatology / reproductive medicine | Broad comprehensive-hospital option | Renji may be a better Shanghai starting point depending on the specialty. |
| Rare or difficult multisystem diagnosis | Useful broad Shanghai referral option | PUMCH is a strong Beijing comparator for complex and multi-system diagnostic cases. |
| Dedicated solid-tumor cancer-center question | Cancer Center plus broad medical support | Fudan University Shanghai Cancer Center may be more disease-specific for many solid tumors. |
How Parkmega Approaches a Ruijin Case
Identify the real question
Diagnosis confirmation, CAR-T eligibility, endocrine management and surgery are different clinical questions and require different referral pathways.
Organize the records
We prioritize pathology, molecular testing, DICOM imaging and prior-treatment history when these affect routing.
Match the Ruijin team
We identify whether hematology, endocrinology, oncology or another department is the logical first contact.
Compare when needed
We can compare Ruijin with another Shanghai or Beijing center when the diagnosis points to a more specialized route.
Is Ruijin the Right Shanghai Hospital for Your Case?
Send the diagnosis, recent medical summary, imaging, pathology or hematology/endocrine results, previous treatment and the decision you need from the specialist team. We’ll identify the likely Ruijin route and compare another Chinese hospital when that makes more sense.
✓ Specialty routing
✓ International access checked
✓ Evidence-first hospital comparison
Related China Hospital Guides
Frequently Asked Questions
Direct answers about Ruijin’s specialties, international access, CAR-T, diabetes, insurance and costs.
Can international patients go to Ruijin Hospital in Shanghai?
Yes. Shanghai’s official International Medical Services directory lists Ruijin Hospital with an international service route at its main Huangpu campus, including English service, a dedicated contact number and email, specialty departments and direct-pay insurer information.
What is Ruijin Hospital best known for?
Ruijin is a broad tertiary teaching hospital with especially strong hematology and endocrine/metabolic programs. Shanghai government and Shanghai Jiao Tong University School of Medicine sources also document oncology, cardiology, neurology, infectious disease, burns, gastroenterology, critical care and other major specialties.
Is Ruijin Hospital a good choice for leukemia or blood cancer?
Ruijin is highly relevant for hematology. Its institutional history is closely associated with acute promyelocytic leukemia, and current Shanghai Jiao Tong University faculty pages document active translational work in leukemia, lymphoma, multiple myeloma and cellular therapies. The correct hematology team depends on the exact diagnosis, molecular findings and previous treatment.
Does Ruijin Hospital offer CAR-T therapy?
Ruijin has documented CAR-T expertise. A 2026 Shanghai Government patient story describes an overseas patient with multiple myeloma who was evaluated by Ruijin’s international medical department and hematology team and treated with CAR-T. This is evidence that selected international CAR-T cases are handled at Ruijin, not a guarantee that every diagnosis or patient is eligible.
Is Ruijin Hospital good for diabetes and endocrinology?
Yes. Endocrinology is one of Ruijin’s major academic and clinical strengths, and Ruijin hosts the Shanghai National Clinical Research Center for Metabolic Diseases and national-level endocrine/metabolic research infrastructure. Diabetes care, endocrine diagnosis and metabolic disease are reasonable reasons to consider Ruijin, but experimental treatments require separate eligibility verification.
Does Ruijin Hospital provide English-language service?
Yes. Shanghai’s official English hospital profile lists English as a service language. More recent multilingual municipal-health profiles also list additional languages, but language coverage can vary by appointment, so confirm the interpreter or language arrangement for the assigned specialist.
How do I contact Ruijin Hospital’s international service?
Shanghai’s official international-service profile lists 021-6467-8970 and vip@rjh.com.cn. The published phone service hours are Monday to Saturday, 8:00–11:30 and 13:30–16:30. Contact details and schedules can change, so reconfirm before travel.
Can Ruijin review my case before I travel to Shanghai?
Remote pre-contact is possible in selected cases. A 2026 Shanghai Government patient story describes an international hematology case that was discussed online before Ruijin accepted the patient for an in-person pre-treatment evaluation. Public sources do not establish a universal formal remote second-opinion product for every specialty.
Can international insurance be used at Ruijin Hospital?
Shanghai’s municipal health profile publishes a direct-pay insurer list for Ruijin’s international service. Direct billing still depends on the exact insurer, policy, treatment and preauthorization, so patients should confirm coverage and any deposit or guarantee-of-payment requirement before admission.
How much does treatment at Ruijin Hospital cost?
There is no reliable universal Ruijin price list for international cases. Costs depend on the diagnosis, specialist route, imaging, laboratory and pathology work, drugs, cellular therapy or procedures, devices, ICU use and length of stay. Request an estimate only after the hospital has reviewed the case and identified the likely treatment pathway.
Sources and Verification
- Shanghai Municipal Commission of Health — Ruijin Hospital international profile. Main international-service address, outpatient/inpatient locations, service hours, English service, specialties, phone, email and direct-pay insurer list. Ruijin international-service profile.
- Shanghai Municipal Government — International Medical Services directory. Current city directory listing Ruijin as an international medical-service provider. Shanghai International Medical Services.
- Shanghai Municipal Government — Shanghai medical institutions, August 2026. Current city directory documenting Ruijin’s multiple campuses. Shanghai medical institutions.
- Shanghai Municipal Health Commission multilingual Ruijin profile, 2025. Current public profile documenting the main-campus international route, emergency location, additional listed service languages and Ruijin’s historical APL and burn-medicine contributions. Municipal-health Ruijin profile.
- Shanghai Jiao Tong University School of Medicine — Ruijin Hospital. Institutional status, Grade 3 Class A status, National Medical Center designation, hospital scale and national key disciplines. SJTU School of Medicine Ruijin profile.
- Shanghai Government Patient Story — February 4, 2026. Documents an overseas multiple-myeloma patient whose case was discussed online before Ruijin’s International Medical Department and hematology team accepted him for evaluation and CAR-T treatment; also reports current growth of foreign-patient use and international-department scale as hospital-reported data. Foreign patients come to Shanghai for hospital expertise.
- Shanghai Government Patient Story — January 29, 2026. Additional official-government reporting on international patients using Ruijin and other Shanghai public hospitals for advanced specialist treatment. Shanghai attracts global patients.
- Shanghai Jiao Tong University School of Medicine — Mi Jianqing. Current Ruijin hematology faculty profile documenting CAR-T/TCR-T research in multiple myeloma, Hodgkin disease and acute lymphocytic leukemia and related clinical translation. Ruijin hematology faculty profile.
- Shanghai Jiao Tong University School of Medicine — Xu Pengpeng. Current Ruijin hematology faculty profile documenting lymphoma clinical/translational research. Ruijin lymphoma research profile.
- Shanghai Jiao Tong University School of Medicine — Cai Xun. Current Ruijin hematology research profile covering AML and APL-related differentiation therapy research. Ruijin AML research profile.
- Shanghai Jiao Tong University School of Medicine — Gu Weiqiong. Current Ruijin endocrinology profile documenting diabetes, obesity and endocrine-disease clinical research. Ruijin endocrinology faculty profile.
- 2026 Journal of Diabetes / Ruijin academic network. Current publication identifying the Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai National Clinical Research Center for Metabolic Diseases and related national research infrastructure at Ruijin. 2026 metabolic-disease center publication.
- Ruijin Hospital official website. Current hospital portal listing International Medical Department and major clinical departments. Ruijin Hospital official website.
Evidence rule: international access, contacts and direct-pay information are grounded primarily in Shanghai Government / Municipal Health Commission sources. Clinical and academic capabilities are grounded in Ruijin/SJTU sources. A single foreign-patient case is evidence that a pathway exists, not evidence of universal eligibility or outcomes.
Last evidence check: September 2026. International contacts, language staffing, insurer contracts, CAR-T availability, clinical-trial status, admission rules and specialist schedules can change; reconfirm before travel.
Get the Ruijin Department Right Before You Travel
Send the diagnosis, imaging, pathology or hematology/endocrine results, previous treatment and current medications. We’ll identify whether Ruijin is a logical fit and what the International Medical Department should confirm before travel.